Rigorous testing has resulted in observations of the Optejet’s durable base unit performing over 30,000 sprays, and 98% of ...

H.C. Wainwright maintained a neutral stance on Eyenovia (NASDAQ:EYEN) shares, reiterating a price target of $2.00. The firm's analyst, Matthew Caufield, highlighted the U.S. Food and Drug ...

Eyenovia (EYEN) announces recent progress on the development of its user-filled spray dispenser. “Millions of consumers have difficulty with ...

NEW YORK – Eyenovia, Inc., a pharmaceutical company specializing in preparations, announced today a reverse stock split of its common shares in a strategic move to comply with Nasdaq's minimum bid ...

Eyenovia, Inc. announced a 1-for-80 reverse stock split of its outstanding common stock, which was approved by its Board of Directors and stockholders. The split will take effect on January 31 ...

Eyenovia had a negative return on equity of 1,108.24% and a negative net margin of 114,639.41%. During the same period in the prior year, the firm earned ($0.18) earnings per share.

Virtual meeting scheduled for 10:00 a.m. ET on January 21st; stockholders must pre-register by 11:59 p.m. ET on January 20thNEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ ...

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its ...

In a recent special meeting, shareholders of Eyenovia (NASDAQ:EYEN), Inc., a pharmaceutical company specializing in preparations, voted in favor of a reverse stock split and an increase in stock ...